Details for New Drug Application (NDA): 089095
✉ Email this page to a colleague
NDA 089095 describes URECHOLINE, which is a drug marketed by Odyssey Pharms and is included in five NDAs. Additional details are available on the URECHOLINE profile page.
The generic ingredient in URECHOLINE is bethanechol chloride. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
The generic ingredient in URECHOLINE is bethanechol chloride. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
Summary for 089095
| Tradename: | URECHOLINE |
| Applicant: | Odyssey Pharms |
| Ingredient: | bethanechol chloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 089095
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Dec 19, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
